《日本胃癌治疗指南2018（第5版）》 - Suppr

Suppr

超能文献

Japanese gastric cancer treatment guidelines 2018 (5th edition).

出版信息

Gastric Cancer. 2021 Jan;24(1):1-21. doi: 10.1007/s10120-020-01042-y. Epub 2020 Feb 14.

DOI:10.1007/s10120-020-01042-y

PMID:32060757

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7790804/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4bb/7790804/d44a688365f1/10120_2020_1042_Fig1_HTML.jpg

相似文献

Japanese gastric cancer treatment guidelines 2018 (5th edition).《日本胃癌治疗指南2018（第5版）》

Gastric Cancer. 2021 Jan;24(1):1-21. doi: 10.1007/s10120-020-01042-y. Epub 2020 Feb 14.

[TNM-7th edition 2009 (UICC/AJCC) and Japanese Classification 2010 in Gastric Cancer. Towards simplicity and standardisation in the management of gastric cancer].[2009年第7版TNM（国际抗癌联盟/美国癌症联合委员会）与2010年日本胃癌分类。迈向胃癌管理的简化与标准化]

Cir Esp. 2011 May;89(5):275-81. doi: 10.1016/j.ciresp.2010.10.011. Epub 2011 Jan 21.

Management of gastric cancer in Asia: resource-stratified guidelines.亚洲胃癌管理：资源分层指南。

Lancet Oncol. 2013 Nov;14(12):e535-47. doi: 10.1016/S1470-2045(13)70436-4.

[Standards for diagnostics and therapy of gastric cancer].[胃癌诊断与治疗标准]

Internist (Berl). 2014 Aug;55(8):925-41. doi: 10.1007/s00108-013-3381-x.

Gastric cancer treatment guidelines in Japan.日本胃癌治疗指南。

Gastric Cancer. 2002;5(1):1-5. doi: 10.1007/s101200200000.

[Evaluation of the gastric cancer treatment guidelines of the Japanese Gastric Cancer Association].[日本胃癌协会胃癌治疗指南的评估]

Gan To Kagaku Ryoho. 2010 Apr;37(4):582-6.

UICC drops the ball in the 8th edition TNM staging of urological cancers.国际抗癌联盟（UICC）在第八版泌尿生殖系统癌症TNM分期中表现不佳。

Histopathology. 2017 Jul;71(1):5-11. doi: 10.1111/his.13200.

[In regard to gastric cancer treatment guidelines--a revised edition].关于胃癌治疗指南——修订版

Gan To Kagaku Ryoho. 2004 Nov;31(12):1947-51.

Cancer of the stomach.胃癌

Gastroenterol Clin Biol. 2006 Sep;30 Spec No 2:2S16-2S23.

New Japanese classifications and treatment guidelines for gastric cancer: revision concepts and major revised points.日本胃癌新分类及治疗指南：修订理念与主要修订要点

Gastric Cancer. 2011 Jun;14(2):97-100. doi: 10.1007/s10120-011-0040-6.

引用本文的文献

Prognostic value of signet-ring cell carcinoma proportion in undifferentiated gastric cancer: Implications for endoscopic treatment decisions.印戒细胞癌比例在未分化型胃癌中的预后价值：对内镜治疗决策的启示

World J Gastroenterol. 2025 Aug 14;31(30):109465. doi: 10.3748/wjg.v31.i30.109465.

The impact of neoadjuvant treatment on early postoperative complications and pathological outcomes in gastric cancer patients: A retrospective cohort study.新辅助治疗对胃癌患者术后早期并发症及病理结果的影响：一项回顾性队列研究。

Medicine (Baltimore). 2025 Aug 22;104(34):e43934. doi: 10.1097/MD.0000000000043934.

The immune signatures predict gastric/gastroesophageal junction cancer response to first-line anti-PD-1 blockade or chemotherapy.免疫特征可预测胃癌/胃食管交界癌对一线抗程序性死亡蛋白1（PD-1）阻断治疗或化疗的反应。

BMC Cancer. 2025 Aug 25;25(1):1369. doi: 10.1186/s12885-025-14805-6.

Nomogram models for predicting lymph node metastasis and prognosis in early gastric cancer 60 or older: a population-based cohort study.预测60岁及以上早期胃癌淋巴结转移和预后的列线图模型：一项基于人群的队列研究。

Discov Oncol. 2025 Aug 13;16(1):1543. doi: 10.1007/s12672-025-03412-3.

Positive lymph node ratio as a nodal staging system to avoid stage migration between remnant and primary proximal gastric cancers.阳性淋巴结比率作为一种淋巴结分期系统，以避免残余近端胃癌和原发性近端胃癌之间的分期迁移。

Sci Rep. 2025 Aug 5;15(1):28623. doi: 10.1038/s41598-025-13766-x.

Postoperative liver dysfunction in gastric cancer patients following early enhanced nutritional protocols: a retrospective observational study.早期强化营养方案对胃癌患者术后肝功能障碍的影响：一项回顾性观察研究

J Pharm Health Care Sci. 2025 Aug 4;11(1):64. doi: 10.1186/s40780-025-00473-y.

Hepatic resection improves the prognosis of gastric cancer liver metastasis patients with resected primary lesions.肝切除可改善原发性病灶已切除的胃癌肝转移患者的预后。

Transl Gastroenterol Hepatol. 2025 Jun 3;10:48. doi: 10.21037/tgh-24-126. eCollection 2025.

Diagnostic challenges of rarely well-differentiated adenocarcinoma of the stomach.胃高分化腺癌的诊断挑战

Pathol Oncol Res. 2025 Jul 7;31:1612163. doi: 10.3389/pore.2025.1612163. eCollection 2025.

Usefulness of the preoperative Prognostic Immune and Nutritional Index as a prognostic predictor for patients with gastric cancer.术前预后免疫和营养指数作为胃癌患者预后预测指标的效用

Oncol Lett. 2025 Jul 8;30(3):435. doi: 10.3892/ol.2025.15181. eCollection 2025 Sep.

Comparison of laparoscopic and open total gastrectomy with D2 lymphadenectomy for gastric cancer: a propensity score matched study.腹腔镜与开放全胃切除术联合D2淋巴结清扫术治疗胃癌的比较：一项倾向评分匹配研究

BMC Surg. 2025 Jul 16;25(1):298. doi: 10.1186/s12893-025-03044-y.

本文引用的文献

Docetaxel plus cisplatin and S-1 versus cisplatin and S-1 in patients with advanced gastric cancer (JCOG1013): an open-label, phase 3, randomised controlled trial.多西他赛联合顺铂和 S-1 对比顺铂和 S-1 一线治疗晚期胃癌的疗效（JCOG1013）：一项开放标签、三期、随机对照临床试验。

Lancet Gastroenterol Hepatol. 2019 Jul;4(7):501-510. doi: 10.1016/S2468-1253(19)30083-4. Epub 2019 May 14.

Addition of Docetaxel to Oral Fluoropyrimidine Improves Efficacy in Patients With Stage III Gastric Cancer: Interim Analysis of JACCRO GC-07, a Randomized Controlled Trial.多西他赛联合口服氟嘧啶可提高 III 期胃癌患者的疗效：JACCRO GC-07 随机对照试验的中期分析。

J Clin Oncol. 2019 May 20;37(15):1296-1304. doi: 10.1200/JCO.18.01138. Epub 2019 Mar 29.

Single-arm confirmatory trial of laparoscopy-assisted total or proximal gastrectomy with nodal dissection for clinical stage I gastric cancer: Japan Clinical Oncology Group study JCOG1401.腹腔镜辅助全胃或近端胃切除术加淋巴结清扫术治疗临床Ⅰ期胃癌的单臂确证性临床试验：日本临床肿瘤学组研究 JCOG1401。

Gastric Cancer. 2019 Sep;22(5):999-1008. doi: 10.1007/s10120-019-00929-9. Epub 2019 Feb 20.

Effect of Laparoscopic Distal Gastrectomy vs Open Distal Gastrectomy on Long-term Survival Among Patients With Stage I Gastric Cancer: The KLASS-01 Randomized Clinical Trial.腹腔镜远端胃切除术与开腹远端胃切除术治疗Ⅰ期胃癌患者的长期生存效果比较：KLASS-01 随机临床试验。

JAMA Oncol. 2019 Apr 1;5(4):506-513. doi: 10.1001/jamaoncol.2018.6727.

Five-weekly S-1 plus cisplatin therapy combined with trastuzumab therapy in HER2-positive gastric cancer: a phase II trial and biomarker study (WJOG7212G).S-1 每周 5 次联合顺铂治疗与曲妥珠单抗治疗用于人表皮生长因子受体 2 阳性胃癌：一项 II 期试验和生物标志物研究（WJOG7212G）。

Gastric Cancer. 2018 Jan;21(1):84-95. doi: 10.1007/s10120-017-0725-6. Epub 2017 May 11.

Nab-paclitaxel versus solvent-based paclitaxel in patients with previously treated advanced gastric cancer (ABSOLUTE): an open-label, randomised, non-inferiority, phase 3 trial.奈达铂紫杉醇对比既往治疗的晚期胃癌患者中的溶剂型紫杉醇（ABSOLUTE）：一项开放标签、随机、非劣效、3 期临床试验。

Lancet Gastroenterol Hepatol. 2017 Apr;2(4):277-287. doi: 10.1016/S2468-1253(16)30219-9. Epub 2017 Jan 19.

A Scoring System to Stratify Curability after Endoscopic Submucosal Dissection for Early Gastric Cancer: "eCura system".一种用于早期胃癌内镜下黏膜下剥离术后可治愈性分层的评分系统：“eCura系统”。

Am J Gastroenterol. 2017 Jun;112(6):874-881. doi: 10.1038/ajg.2017.95. Epub 2017 Apr 11.

A non-randomized confirmatory trial of an expanded indication for endoscopic submucosal dissection for intestinal-type gastric cancer (cT1a): the Japan Clinical Oncology Group study (JCOG0607).内镜黏膜下剥离术治疗肠型胃癌（cT1a）扩大适应证的非随机确证性临床试验：日本临床肿瘤学组研究（JCOG0607）。

Gastric Cancer. 2018 Jan;21(1):114-123. doi: 10.1007/s10120-017-0704-y. Epub 2017 Feb 21.

Effect of Fluorouracil, Leucovorin, and Oxaliplatin With or Without Onartuzumab in HER2-Negative, MET-Positive Gastroesophageal Adenocarcinoma: The METGastric Randomized Clinical Trial.氟尿嘧啶、亚叶酸和奥沙利铂联合或不联合奥妥珠单抗治疗人表皮生长因子受体 2（HER2）阴性、间质上皮转化因子（MET）阳性胃食管腺癌的效果：METGastric 随机临床试验。

JAMA Oncol. 2017 May 1;3(5):620-627. doi: 10.1001/jamaoncol.2016.5580.

Results of a nation-wide retrospective study of lymphadenectomy for esophagogastric junction carcinoma.一项关于食管胃交界癌淋巴结清扫术的全国性回顾性研究结果。

Gastric Cancer. 2017 Mar;20(Suppl 1):69-83. doi: 10.1007/s10120-016-0663-8. Epub 2016 Oct 28.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验